Ibibazo: Ubuvuzi bwa CAR-T kuri BIOOCUS
Ubuvuzi bwa CAR-T (Chimeric Antigen Receptor T-selile) ni uburyo bwiza bwo gukingira indwara bukoresha T-selile zahinduwe mu buryo bwa genoside mu kurwanya no kwica kanseri. Ikoreshwa cyane cyane kuvura kanseri yamaraso nka leukemia na lymphoma.
Inzira ya CAR-T mubisanzwe ifata ibyumweru 6-8, kuva T-selile ikusanya. Icyiciro cyo kwitegura, harimo gukuramo no guhindura T-selile, mubisanzwe bifata ibyumweru 3-4.
Ubuvuzi bwa CAR-T busanzwe bukoreshwa ku barwayi bafite kanseri y’amaraso yihariye nka B-selile leukemia, lymphoma, nizindi ndwara mbi ziterwa na hematologique. Kwemererwa kugenwa nimpamvu nkubuvuzi bwabanje nubuzima bwumurwayi muri rusange.
Ingaruka zikunze kugaragara zirimo umuriro, gukonja, umuvuduko ukabije wamaraso, hamwe na syndrome ya cytokine (CRS), bishobora gutera ubudahangarwa bw'umubiri. Abarwayi bakurikiranirwa hafi mugihe cyo kuvura kugirango bakemure izo ngaruka.
Uzakenera kwipimisha neza kugirango umenye ko uri umukandida ukwiye. Ibi birimo ibizamini byamaraso, gufata ibibyimba, no gusuzuma amateka yubuvuzi bwawe. Tuzahuza kandi ingendo zawe hamwe nibitaro.
Nibyo, turashishikariza abarwayi kuzana umuryango cyangwa inshuti kugirango babashyigikire mugihe cyo kumara. Dutanga ubufasha kumacumbi hamwe ningendo zingendo kuri mugenzi wawe.
BIOOCUS itanga ubufasha bwuzuye kubarwayi mpuzamahanga, harimo ubufasha bwa viza, ibyifuzo byindege, hamwe nuburaro. Tuzakuyobora mubikorwa kandi tumenye ko uhageze neza.
Mugihe ubuvuzi bwa CAR-T bukunze kuvurwa inshuro imwe, abarwayi bamwe bashobora gukenera izindi infusion. Tuzaganira kubibazo byawe na gahunda yo gukurikirana imiti nibikenewe.
Nyuma yo kuvura CAR-T, uzakenera gusurwa buri gihe kugirango ukurikirane ubuzima bwawe nuburyo bwiza bwo kuvura. Ibi bishobora kubamo gupima amaraso, gufata amashusho, no gukurikirana ibimenyetso. Gukurikirana igihe kirekire ni ngombwa kugirango habeho ibisubizo byiza.
Mugihe ubuvuzi bwa CAR-T bushobora gutanga imiti irambye, burigihe hariho ibyago byo kongera kanseri. Gukomeza gukurikirana no gukurikirana ni ngombwa kugirango umenye ibimenyetso byose byo gusubira hakiri kare.
Ibibazo: Ubuvuzi bwa TIL kuri BIOOCUS
Ubuvuzi bwa TIL (Tumor-Infiltrating Lymphocyte) nuburyo bwo gukingira indwara aho T-selile ziva mu kibyimba cy’umurwayi zisarurwa, zikagurwa muri laboratoire, hanyuma zongera gushyirwa mu murwayi kugira ngo zite kanseri ya kanseri.
Uburyo bwo kuvura TIL mubisanzwe bifata ibyumweru 6-8. Intambwe yambere yo gukusanya ibibyimba no guhinga T-selile muri laboratoire bifata ibyumweru 3-4, bigakurikirwa na chimiotherapie hamwe na TIL.
Ubuvuzi bwa TIL bukoreshwa cyane cyane kubyimba bikomeye nka melanoma, kanseri y'ibihaha, kanseri y'inkondo y'umura, hamwe na kanseri yateye imbere cyangwa metastatike. Kwemererwa gushingiye ku bwoko bwibibyimba no gusubiza kubuvuzi bwambere.
Ingaruka zo kuvura TIL zishobora kuba zirimo umunaniro, umuriro, isesemi, na syndrome ya cytokine (CRS). Kimwe na CAR-T, ubuvuzi burakurikiranirwa hafi kugirango umutekano w’abarwayi urangire.
Kimwe na CAR-T, kwitegura bikubiyemo isuzuma ryuzuye ryubuvuzi, harimo amashusho, gupima amaraso, na biopsy yibibyimba. Tumaze kwemererwa, tuzaganira ku buryo bwihariye bwo guhuza no guhuza ibikoresho kugira ngo ugume mu Bushinwa.
Nibyo, turashishikariza abarwayi kuzana umuryango cyangwa inshuti kugirango babashyigikire mugihe cyo kumara. Dutanga ubufasha kumacumbi hamwe ningendo zingendo kuri mugenzi wawe.
BIOOCUS itanga ubufasha bwuzuye kubarwayi mpuzamahanga, harimo ubufasha bwa viza, ibyifuzo byindege, hamwe nuburaro. Tuzakuyobora mubikorwa kandi tumenye ko uhageze neza.
Igiciro cyo kuvura TIL muri BIOOCUS mubusanzwe kiri hagati y $ 100.000 kugeza $ 150.000 USD, bitewe nuburyo bugoye bwo kuvura kandi bisaba ubuvuzi bukurikiranwa.
Niba imiti ya TIL igaragaye ko ari ingirakamaro, ariko kanseri igaruka, hashobora gutekerezwa izindi infusion. Tuzakurikirana iterambere ryawe kandi tuganire kubundi buryo bwo kuvura nyuma yo kwinjiza bwa mbere.
Nyuma yo kuvura TIL, abarwayi bazakenera kwisuzumisha buri gihe kugirango bakurikirane kanseri kandi bakemure ingaruka zose z'igihe kirekire. Ibi birashobora kubamo amashusho, gupima amaraso, no gukurikirana sisitemu yumubiri.
Mugihe ubuvuzi bwa TIL bushobora gutanga imiti irambye, burigihe hariho ibyago byo kongera kanseri. Gukomeza gukurikirana no gukurikirana ni ngombwa kugirango umenye ibimenyetso byose byo gusubira hakiri kare.